Hepatic schistosomiasis, upper gastrointestinal bleeding, and health related quality of life measurements from the Albert Nile Basin

Opio, Christopher K.; Kazibwe, Francis; Rejani, Lalitha; Kabatereine, Narcis B.; Ocama, Ponsiano

doi:10.1186/s41687-021-00389-9

Table 2 Medians (95% confidence intervals) of EQ-VAS, EQ-5D index, and derived disability weights by different clinical factors

From: Hepatic schistosomiasis, upper gastrointestinal bleeding, and health related quality of life measurements from the Albert Nile Basin

	n	EQ-VAS		EQ-5D index		EQ-VAS derived disability weights		EQ-5D index derived disability weights
	n	Median	95% CI	Median	95% CI	Median	95% CI	Median	95% CI
All participants	101	70	60, 70	0.59	0.59, 0.62	0.30	0.30, 0.40	0.34	0.31, 0.35
Age, years
18–29	4	75	70, 90	0.67	0.59, 0.73	0.25	0.10, 0.30	0.26	0.21, 0.35
30–39	25	70	60, 80	0.62	0.52, 0.62	0.30	0.20, 0.40	0.31	0.31, 0.38
40–49	36	65	50, 70	0.62	0.59, 0.62	0.35	0.30, 0.50	0.31	0.31, 0.35
50–59	18	50	40, 80	0.59	0.09, 0.73	0.50	0.20, 0.60	0.38	0.31, 0.53
60–69	15	60	50, 70	0.52	0.19, 0.62	0.40	0.30, 0.50	0.40	0.31, 0.50
≥ 70	3	30	20, 60	− 0.13	− 0.18, − 0.13	0.70	0.40, 0.80	0.78	0.77, 0.78
Men	40	70	50, 80	0.62	0.59, 0.66	0.30	0.20, 0.50	0.31	0.30, 0.35
Women	61	60	50, 70	0.55	0.52, 0.62	0.40	0.30, 0.50	0.36	0.31, 0.40
Fisherman	14	70	50, 80	0.68	0.58, 0.79	0.30	0.20, 0.50	0.33	0.21, 0.42
Farmer	76	70	60, 70	0.65	0.62, 0.70	0.30	0.30, 0.40	0.35	0.31, 0.38
Jaundice
No	90	70	60, 70	0.62	0.59, 0.62	0.30	0.30, 0.40	0.31	0.31, 0.35
Yes	11	60	40, 70	0.52	− 0.16, 0.59	0.40	0.30, 0.60	0.40	0.34, 0.68
Edema
No	90	70	60, 70	0.62	0.59, 0.62	0.30	0.30, 0.40	0.31	0.31, 0.35
Yes	11	40	30, 50	0.15	− 0.18, 0.62	0.60	0.50, 0.70	0.48	0.31, 0.77
Splenomegaly
No	8	65	20, 90	0.57	− 0.35, 0.80	0.35	0.10, 0.80	0.36	0.17, 0.99
Yes	89	70	60, 70	0.62	0.59, 0.62	0.30	0.30, 0.40	0.32	0.31, 0.35
Tense ascites (exam difficult)	4	30	10, 40	0.12	− 0.59, 0.15	0.70	0.60, 0.90	0.51	0.48, 1.15
Praziquantel
No	11	80	70, 90	0.66	0.52, 0.80	0.2	0.10, 0.30	0.30	0.17, 0.34
Yes	90	60	50, 70	0.59	0.52, 0.62	0.4	0.30, 0.50	0.35	0.31, 0.40
Body mass index ≤ 18.5
No	84	70	60, 70	0.62	0.59, 0.62	0.3	0.30, 0.40	0.31	0.31, 0.35
Yes	17	50	40, 70	0.52	1.66, 0.62	0.5	0.30, 0.60	0.41	0.31, 0.78
Liver fibrosis pattern score
C	5	60	50, 90	0.59	− 0.13, 0.70	0.4	0.10, 0.50	0.35	0.21–0.78
D	34	70	60, 80	0.62	0.55, 0.66	0.3	0.20, 0.40	0.31	0.30, 0.35
E	21	70	50, 80	0.62	0.52, 0.62	0.3	0.20, 0.50	0.32	0.31, 0.40
F	3	50	50, 80	0.59	0.52, 0.62	0.5	0.20, 0.50	0.36	0.31, 0.40
X	38	60	50, 70	0.59	0.24, 0.62	0.35	0.31, 0.42	0.35	0.31, 0.42
Ascites by ultrasound
No	87	70	60, 70	0.62	0.59, 0.62	0.3	0.30,0.40	0.31	0.31, 0.35
Yes	14	40	30, 50	0.15	− 1.26, 0.52	0.6	0.50, 0.70	0.48	0.40, 0.77
Varices
No	18	70	50, 80	0.6	0.52, 0.67	0.3	0.20, 0.50	0.33	0.30, 0.40
Yes	83	70	50, 70	0.59	0.52, 0.63	0.3	0.30, 0.50	0.35	0.31, 0.36
Acute upper gastrointestinal bleeding
No	79	70	70, 80	0.62	0.59, 0.62	0.3	0.20, 0.30	0.31	0.31, 0.35
Yes	22	40	30, 50	0.2	− 0.13, 0.59	0.6	0.50, 0.70	0.45	0.36, 0.68
Urine CCA
No	93	70	60, 70	0.59	0.52, 0.62	0.3	0.30,0.40	0.35	0.31, 0.36
Yes	8	65	0, 80	0.6	− 0.13, 0.62	0.35	0.20, 1.0	0.33	0.31, 0.78
Anemia grade (gm/dl)
< 6.5	20	50	40, 70	0.6	0.29, 0.64	0.5	0.30, 0.60	0.40	0.36, 0.71
6.5–7.9	12	50	31, 69	0.56	0.47, 0.55	0.5	0.31, 0.69	0.44	0.35, 0.53
8.0–9.4	15	60	50, 80	0.65	0.60, 0.70	0.4	0.20, 0.50	0.35	0.31, 0.40
9.5–10.9	16	65	55, 80	0.72	0.62, 0.79	0.35	0.20, 0.45	0.28	0.21, 0.38
≥ 11.0	38	75	70, 80	0.7	0.69, 0.70	0.25	0.20, 0.30	0.31	0.30, 0.31
Hepatitis B surface antigen positive
No	94	60	50, 70	0.65	0.62, 0.70	0.4	0.30, 0.50	0.35	0.31, 0.38
Yes	7	80	70, 87	0.7	0.65, 0.79	0.2	0.13, 0.30	0.31	0.21, 0.35

UGIB-upper gastrointestinal bleeding, 95CI – 95% confidence intervals

Back to article page